Advertisement

Topics

Neos Therapeutics Announces Launch Of Cotempla XR-ODT (Methylphenidate) Extended-Release Orally Disintegrating Tablets For The Treatment Of ADHD In Patients 6 To 17 Years Old

20:00 EDT 4 Sep 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Neos Therapeutics Announces Launch Of Cotempla XR-ODT (Methylphenidate) Extended-Release Orally Disintegrating Tablets For The Treatment Of ADHD In Patients 6 To 17 Years Old

NEXT ARTICLE

More From BioPortfolio on "Neos Therapeutics Announces Launch Of Cotempla XR-ODT (Methylphenidate) Extended-Release Orally Disintegrating Tablets For The Treatment Of ADHD In Patients 6 To 17 Years Old"

Quick Search
Advertisement